2018 Volume 20 Issue 6 Published: 28 December 2018
  

  • Select all
    |
  • Li Jun, Xie Han, Deng Ang, Ji Lianmei
    2018, 20(6): 401-404.
    Abstract ( ) PDF ( )
  • Chen Zhe, Cong Minghua, Yang Jun, Song Chenxin, Li Xinyan, Li Guohui
    Abstract ( ) PDF ( )
  • Wang Jiabo, Song Haibo, Ning Keyong
    2018, 20(6): 409-412.
    Abstract ( ) PDF ( )
  • Fang Zhiyuan, Li Qian, Luo Jing, Lian Jiangping, Zhou Nan
    Abstract ( ) PDF ( )
    ObjectiveTo analysis the rationality of atorvastatin calcium and simvastatin in outpatient and emergency departments from the perspective of drug interactions.MethodsAll prescrip-tions comprising atorvastatin calcium and simvastatin in the outpatient and emergency departments in Shaanxi Provincial People′s Hospital from July 1 to December 31, 2017 were collected. The potential adverse drug interactions in these prescriptions were analyzed and the rationality of drug uses was determined by referring to the drug labels and relevant domestic and foreign guidelines.ResultsA total of 3 647 prescriptions in the outpatient and emergency departments were collected, of which 2 730 (74.9%) comprised atorvastatin calcium and 917 (25.1%) comprised simvastatin. Among the 3 647 prescriptions, 3 221 (88.3%)  comprised more than one drug, of which 2 432 (75.5%) comprised atorvastatin calcium and 789 (24.5%) comprised simvastatin. In the 3 221 co-prescriptions comprising statins, 878 (27.3%) comprised other substrates of cytochrome P450 (CYP) 3A4, mainly including adenosine diphosphate receptor inhibitors, calcium channel blockers, and proton pump inhibitors, of which clopidogrel and nifedipine were used more frequently; 311 (9.7%) comprised CYP 3A4 inhibitors, mainly including calcium channel blockers, anti-arrhythmia agents, immunosuppressive agents, and antibacterial drugs, of which amlodipine and diltiazem were used more frequently; 17 (0.5%) comprised CYP3A4 inductions, including pioglitazone and carbamazepine. Among the co-prescriptions of statins and CYP 3A4 inhibitors, 6 prescriptions comprised incompatibility drugs (simvastatin combined with clarithromycin) and 15 prescriptions comprised simvastatin or atorvastatin calcium with dose higher than the recommended.ConclusionDrug combination of atorvastatin calcium or simvastatin in some prescriptions of Shaanxi Provincial People′s Hospital is unreasonable, mainly shown as being combined with drugs having potential adverse interactions or overdosage when combined with CYP 3A4 inhibitors.
  • Chen Di, Zhao Ming, Liang Liang, Zhu Yuanchao, Yang Liping
    Abstract ( ) PDF ( )
    ObjectiveTo analyze the relationship between glutathione S-transferase P1 (GSTP1) 313A>G polymorphism and the adverse reactions induced by cyclophosphamide (CP).MethodsThe clinical research literature about the relationship between GSTP1 313A>G polymorphism and the adverse reactions induced by CP were collected from related domestic and foreign databases up to July, 2017. The quality of the literature was evaluated by STREGA criterion. The meta-analysis was conducted by RevMan 5.2 software and the results were expressed as relative risk (RR) and 95% confidence interval (CI).ResultsA total of 7 articles were included in the meta-analysis and their quality evaluation results were reliable (all scores≥3), involving 1 305 patients. The results of meta-analysis showed that the differences of incidence of  leukopenia, neutropenia, anemia, thrombocytopenia, myelosuppression, and infection after the treatments of CP combined with other chemotherapeutics between the patients with GSTP1 313A>G AA genotype and GSTP1 313A>G AG/GG genotype were not statistically significant (P>0.05 for all); the incidence of gastrointestinal reactions in patients with GSTP1 313A>G AA genotype was significantly lower than that in patients with GSTP1 313A>AG/GG genotype (RR=0.46, 95%CI: 0.22-0.97, P=0.004); the incidence of myelosuppression after the treatment of CP alone in patients with GSTP1 313A>G AA genotype was significantly lower than that in patients with GSTP1 313A>G AG/GG genotype (RR=0.27, 95%CI: 0.08-0.91, P=0.03).ConclusionThe gastrointestinal reactions induced by CP combined with other chemotherapeutics and myelosuppression induced by CP alone may be related to the polymorphism of GSTP1 313A>G.
  • Chen Jingcheng, Ji Yuan, Zhu Meng, Zhou Xuejun, Zhu Aoshuang
    Abstract ( ) PDF ( )
    ObjectiveTo compare the efficacy and safety of long-term use of dabigatran and warfarin for prevention of stroke in elderly patients with atrial fibrillation. MethodsThe study was designed as a prospective randomized controlled trial. The subjects were outpatients or inpatients who were diagnosed as non-valvular atrial fibrillation and needed anticoagulant therapy in Changzhou No.2 People′s Hospital. The study started on March 20, 2015. Patients in accordance with the inclusion criteria were randomly divided into the dabigatran group (dabigatran 110 mg, twice daily) and warfarin group (warfarin dose was adjusted by regular follow-up results to maintain INR in the range of 2.0-3.0). After two years of follow-up, effectiveness of preventing thromboembolism events and occurrence of hemorrhagic events were compared between the two groups; occurrence of extracranial hemorrhage was also compared in patients with different ages (<60 years old group, 60-<80 years old group,  ≥80 years old group) between the two groups.ResultsUp to October 2015, a total of 180 patients were enrolled, including 114 males (63.3%) and 66 females (36.7%); 65 patients (36.1%) were <60 years old, 108 patients (60.0%) were 60-<80 years old, and 7 (3.9%) were ≥80 years old. There were 90 patients in the dabigatran group and in the warfarin group, respectively. During the period of 2-year follow-up, stroke and non-central nervous system embolism occurred in 6 patients and intracranial hemorrhage in 5 patients in each group, extracranial hemorrhage occurred respectively in 12 and 16 patients in the warfarin and dabigatran groups, without statistically significant differences (P>0.05 for all comparisons). Comparisons of the extracranial hemorrhage incidences in patients with different ages between the 2 groups showed that the incidence of extracranial hemorrhage in patients <60 years old in the dabigatran group was lower than that in the warfarin group (11.4% vs. 13.3%); the incidences of extracranial hemorrhage in patients aged 60-<80 and ≥80 years in the dabigatran group were higher than those in the warfarin group (19.6% vs. 12.2%, 50.0% vs. 33.3%, respectively), without statistically significant differences (P>0.05 for all comparisons).ConclusionsThe effectivenessfor preventing stroke and the incidences of hemorrhagic events were respectively similar in elderly atrial fibrillation patients with long-term use of dabigatran and warfarin. The risk of extracranial hemorrhage in very elderly patients needs to be further studied by expanding the sample size.
  • Lin Zhiqiang, Wang Canming, Hong Shanshan, Wu Namei
    Abstract ( ) PDF ( )
    ObjectiveTo explore the predictive value of intradermal test on anaphylaxis induced by ceftriaxone sodium retrospectively.MethodsMedical records of patients who underwent intradermal test before ceftriaxone sodium treatment in the First Hospital of Quanzhou Affiliated to Fujian Medical University from November 2013 to June 2015 were collected with random equidistant sampling and analyzed retrospectively. The patients were divided into the positive intradermal test group and the negative intradermal test group according to the results of intradermal test. The situation of medication in patients in the positive intradermal test group and the ages, onset time of anaphylaxis, clinical manifestations, and outcomes in patients with allergic reactions after ceftriaxone sodium treatment in the negative intradermal test group were analyzed, respectively. The difference between the incidence of anaphylactic reactions after ceftriaxone sodium treatment in the negative intradermal test group and the hypothetical incidence of anaphylactic reactions after ceftriaxone sodium treatment without intradermal test were calculated according to Poisson distribution principle.ResultsA total of 943 patients were enrolled in the study, including 30 patients (3.18%) in the positive intradermal test group and 913 patients (96.82%) in the negative intradermal test group. Neither the positive and negative control tests nor the provocative tests were performed in patients in the positive intradermal test group and no allergic reactions appeared in these patients in the following treatments with cefoperazone sodium and sulbactam sodium, ceftizoxime, azithromycin, levofloxacin, amoxicillin sulbactam, teicoplanin, and moxifloxacin, respectively. Ten (1.1%) of 913 patients in the negative intradermal test group developed anaphylaxis during the use of ceftriaxone sodium, the incidence of anaphylactic reaction was 1.10%, in whom male and female were 5 respectively, aged 10 months to 52 years, 6 patients were  10 years old. Of the 10 patients with anaphylactic reactions, 4 developed within 20 minutes and 6 developed 4 to 10 days, respectively after the administration. The main symptoms were rash and pruritus, which improved after drug withdrawal and symptomatic treatments. There were no significant difference (u=0.288, P=0.77) between the incidence of anaphylactic reactions in the negative intradermal test group (1.1%) and the hypothetical incidence of ceftriaxone sodium-induced anaphylactic reactions without intradermal test (1.0%).ConclusionThe incidence of anaphylaxis did not decrease significantly in patients with negative intradermal test, suggesting that the intradermal test has no obvious value to predict the occurrence of ceftriaxone sodium-induced anaphylaxis.
  • Wu Xiaoyan, Zhang Helen, Cai Haodong
    Abstract ( ) PDF ( )
    In the developed countries such as the United States, Canada, and Australia, phar-macists play an important role not only in pharmacy services, but also in immunization and vaccine management. The American Pharmacists Association (APhA) has been training pharmacists in vaccine management since 1994. The American Hospital Pharmacist Association formulated the guidelines on the pharmacist′s role in immunization in 2003. Since then, the pharmacists began to involve in procurement, distribution, prescription, and immunization of vaccine. In recent years, the pharmacists in France, Australia, Canada, and other countries have been involving in immunization and vaccine management in succession, and even playing an important role in all aspects of vaccine management (such as procurement, storage, prescription and dispensing, vaccine consultation, immunization, vaccine adverse events reporting, public health education, and etc.). The experience of foreign pharmacists participating in immunization is worth learning.
  • Xian, Zhang Pei, Wang Yulai, Lu Zhen, Sun Haiyan
    Abstract ( ) PDF ( )
    Two male patients (patient 1, 75 years old; patient 2, 63 years old)  underwent percutaneous coronary intervention for acute coronary syndrome. After operation, they were given ticagrelor 90 mg twice daily orally to prevent stent thrombosis. Two patients developed chest tightness and respiratory depression both about 4 hours after their first dose, with decreased respiratory rates of 9-12 and 9-13 breaths/min, respectively. In addition, patient 1 developed sleep apnea on the night after the operation. Ticagrelor was stopped and replaced by clopidogrel on the third and second day, respectively in the 2 patients. After 12 and 10 hours of ticagrelor withdrawal, the respiratory depression disappeared and did not recur at 3 and 6 days of follow-up.
  • Lu Jianping, Liu Min, Qi Xu, Luo Can
    Abstract ( ) PDF ( )
    A 60-year-old male patient received continuously intravenous pump of pituitrin at a speed of 1.92 U/h for 5 days in a local hospital for intermittent hemoptysis 4 days due to fish bone stuck in throat. The amount of hemoptysis was slightly reduced, accompanied by watery stools twice during the treatment. On day 11 after hemoptysis occurrence, the patient was admitted to the Jiangsu Province Hospital due to aggravation of the disease. Repeated hemoptysis continued from the night of admission to the next morning. Then intravenously pump of pituitary at a speed of 1.92 U/h (24 U/d) was given. About 8 hours later, the patient developed abdominal pain and watery stools 5 times within 4 hours. Diarrhea caused by pituitrin was considered, excluding intestinal infection by laboratory tests. Then the pump speed was reduced to 1.73 U/h and continuously intravenous pump of phentolamine was added at a speed of 2 mg/h. Diarrhea did not recur. On day 6 of admission, the patient developed mental confusion, irrelevant answers to questions, localization disorder, dysphoria, and so on. Intracranial hemorrhage and cerebral infarction was ruled out by cranial CT examination. Electrolytes test showed blood sodium 111 mmol/L and blood potassium 2.9 mmol/L. Psychiatric symptoms secondary to electrolyte disturbances caused by pituitrin were considered. The pump speed of pituitrin was adjusted to 0.77 U/h and electrolytes supplements were given. Two days later, the patient′s mental symptoms disappeared.
  • Zhang Yueli, Qin Wangjun, Deng Ang
    Abstract ( ) PDF ( )
    An 81-year-old male patient received an IV infusion of zoledronic acid 4 mg once monthly for prostate cancer with bone metastasis in a local hospital. After 31 times of administration, the medication was given once every 3 months and after 3 times of treatment, the drug was stopped. The total accumulated dose of zoledronic acid was 136 mg. Two months after drug withdrawal, the patient developed pain in the left upper jaw when chewing food. He was diagnosed with endodontitis and 4 times of arrachement was performed in the local hospital. After the last operation, the wound did not heal with local pyorrhea and pain. The CT examination in China-Japan Friendship Hospital showed the osteonecrosis of left maxilla, which was considered to be related to zoledronic acid. Intravenous infusion of cefuroxime sodium 1.5 g and metronidazole 0.5 g twice daily, and gargle with 0.02% chlorhexidine acetate solution 20 ml thrice daily were given. The patient underwent debridement of infection focus in left maxilla. The medications after the operation were as the same as before, except adding regional rinsing with 0.9% sodium chloride injection. On day 4 after operation, the local inflammation in left maxilla improved and 3 weeks later, the wound healed.
  • Zeng Lu, Zhou Ling
    Abstract ( ) PDF ( )
    A 72-year-old male patient who had undergone percutaneous coronary intervention (PCI) twice previously was admitted to the First Affiliated Hospital of Soochow University  because of relapsing coronary artery stenosis and scheduled to undergo PCI again. Previously, he was given a routine dose of dual antiplatelet therapy (clopidogrel 75 mg/d and aspirin 100 mg/d) orally after the two PCI without any obvious adverse reactions. On the day of admission, the patient received a low loading dose of clopidogrel (300 mg) and aspirin (100 mg) orally, and then developed acute visible hematuria in about 2 hours after the medication. The ultrasonography revealed blood clots in his bladder and routine urine test revealed red blood cells 58 686 per microlitre. On day 2 of admission, not aspirin but clopidogrel was discontinued. On day 5 of admission, his urine color and ultrasound imaging of the urinary system returned to normal. On day 8, his routine urine test showed normal and clopidogrel 50 mg/d was given. On day 15, the dose of clopidogrel was increased to 75 mg/d. On day 19, the patient received PCI, implanting a drug-eluting stent in the left anterior descending coronary artery, and dual antiplatelet therapy was given at routine dose after the operation. On day 3 of postoperation, the patient recovered well and was discharged from hospital. After 1 month of follow-up, hematuria did not recur.
  • Qi Xiaolian
    2018, 20(6): 450-451.
    Abstract ( ) PDF ( )
    A 35-year-old female patient with acute cerebral infarction received an IV infusion of azithromycin 0.5 g once daily for combination with pneumonia. About 10 minutes after completing the first infusion, scattered red miliary rash with itching appeared on the patient′s upper limbs, chest, and back. Drug eruption was considered, and dexamethasone 10 mg by an IV injection and loratadine tablets 10 mg by mouth once daily were given. On day 2 of admission, an IV infusion of etimicin sulfate 0.3 g, added into 0.9% sodium chloride injection 250 ml, was given once daily as anti-infective treatment. On day 7, with the disappearance of rash and itching, dexamethasone was replaced by prednisone tablets 30 mg orally once daily, and finally prednisone but not loratadine tablets were discontinued on day 14 through gradual reduction dose of 10 mg every 3 days. On day 15, the patient developed systemic diffuse erythema and facial and limb edema, and then an IV injection of dexamethasone 10 mg once daily was given again. On day 17, with the disappearance of erythema and reduction of edema, desquamation occurred on the patient′s face, body and limbs, which was diagnosed as exfoliative dermatitis, and topical 0.1% halcinonide solution mixed with Yumeijing moisturizer was given externally thrice daily. On day 19, the patient′s skin desquamation improved and edema subsided, and then the dose of dexamethasone was reduced to 5 mg once daily. On day 22, as the desquamation became slighter, dexamethasone was replaced by prednisone tablets 30 mg orally once daily, and the dose of prednisone was gradually reduced by 5 mg every 5 days. On day 26, all symptoms on the patient′s skin disappeared. The rash did not recur at 1 month of follow-up.
  • Chang Ying
    Abstract ( ) PDF ( )
    A 62-year-old male patient with B cell non-Hodgkin′s lymphoma received chemotherapy of rituximab combined with cyclophosphamide, epirubicin, vincristine, and prednisone. No abnormality in the chest CT examination was found before treatments. One week after finishing  the second cycle of chemotherapy, the patient developed cough, chest distress, and asthma after exercise, and etc. Lung inflammation was considered and moxalactam was given. However, the patient′s symptoms gradually worsened. One week later, he had difficulty breathing and could not stand. Then he was transferred to the 900th Hospital of the Chinese People′s Liberation Army Joint Service. The chest CT examination showed multiple patchy and network-like changes in bilateral lungs. Interstitial pneumonia was diagnosed, which was considered to be caused by rituximab combined with chemotherapy. Methylprednisolone sodium succinate and cefoperazone sodium and sulbactam sodium were given. One day later, dyspnea and chest tightness relieved obviously; 4 days later, cough and asthma improved significantly; 17 days later, the chest CT reexamination showed that the lesions in bilateral lungs improved.
  • Liu Jue, Li Menghua, Yang Ping, Wu Liming
    Abstract ( ) PDF ( )
    A 51-year-old male patient with renal failure received IV infusions of vancomycin 1.0 g and cefoperazone sodium and sulbactam sodium 2.0 g twice daily for 7 days in a local hospital because of methicillin-resistant staphylococcus aureus infection. On day 22 of drug withdrawal, the patient developed edematous erythema on his face and lower limbs; on day 26 of drug withdrawal, he developed fever and the laboratory tests showed white blood cell (WBC) 19.7×109/L, neutrophile granulocyte 0.67, eosinophile granulocyte 0.16, C reactive protein (CRP) 76.5 mg/L, procalcitonin 10.9 μg/L, alanine aminotrans-ferase (ALT) 68 U/L, alkaline phosphatase (ALP) 452 U/L, γ-glutamyltransferase (γ-GT) 118 U/L, serum creatinine (Scr) 1 323.5 μmol/L, and prothrombin time (PT) 53.5 s. He was treated with IV infusions of methylprednisolone and the above two drugs again in the local hospital. Six days after remedication, his erythema merged and spread to the whole body, which accompanied by systemic desquamation and skin ulcers on his dorsal foot and around the mouth. Then the patient was transferred to the First People′s Hospital of Hangzhou and diagnosed as drug hypersensitivity syndrome, which was considered to be related to the concomitant use of vancomycin and cefoperazone sodium and sulbactam sodium. Symptomatic and supportive treatments were given, including IV infusions of piperacillin sodium and tazobactam sodium 4.5 g twice daily, methylprednisolone 30 mg (the dosage was gradually decreased to 20 mg once daily) twice daily, fresh frozen plasma 400 U, oral antihistamine drugs, topical external medicine, and etc. On day 22 of the above treatments, his edemas subsided and the whole erythema disappeared. The laboratory tests showed WBC 5.6×109/L, eosinophile granulocyte 0, ALT 13 U/L, ALP 66 U/L, γ-GT 54 U/L, Scr 719 μmol/L, and PT 12.7 s.
  • Hou Jiqiu, Zhang Hongmei, Xiao Jinbao, Li Ping
    Abstract ( ) PDF ( )
    A 46-year-old male patient with Hodgkin′s lymphoma received ABVD regimen with pingyangmycin, epirubicin, vindesine, and dacarbazine (the chemotherapy cycle was 28 days). After 4 cycles of chemotherapy, the patient developed obvious dyspnea, which became more serious after activity and did not improve after oxygen inhalation and glucocorticoid treatment. The chemotherapy regimen was changed to CHOPE regimen with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide (the chemotherapy cycle was 28 days). After 1 cycle of the CHOPE chemotherapy, the patient′s dyspnea aggravated. Blood oxygenation analysis showed pH 7.5, arterial oxygen partial pressure 51 mmHg, partial pressure of arterial blood carbon dioxide 32 mmHg, and blood oxygen saturation 0.89. A lot of Velcro rales could be auscultated in bilateral lungs. Chest CT examination showed bilateral pulmonary interstitial changes. Pulmonary interstitial fibrosis induced by pingyangmycin and cyclophospha-mide was considered. The patient was given treatments of IV infusions of methylprednisolone sodium succinate and ambroxol hydrochloride injection, and noninvasive mechanical ventilation. But his condition aggravated progressively and eventually died due to respiratory failure.
  • Zhang Kuishan, Ma Li, Zhang Xin
    Abstract ( ) PDF ( )
    A 70-day-old female infant received propranolol hydrochloride orally for hemangioma. On day 5 after the medication, the infant developed diarrhea and hematochezia. Propranolol hydrochloride was discontinued, and montmorillonite powder 1.0 g and live combined Bifidobacterium, Lactobacillus and Streptococcus therophilus tablets 0.5 g were given thrice daily orally. Three days later, the symptoms disappeared and fecal occult blood test showed negative. One week later, propranolol hydrochloride was given again and, 2 days later, the above symptoms recurred. Propranolol hydrochloride was stopped again and above therapeutic regime as well as Ding Guier umbilical paste was given (1 paste/d). The symptoms did not improve after 7 days of the treatment. The diagnosis of allergic colitis was confirmed through colonoscopy and intestinal mucosal biopy. Montmorillonite powder 1.0 g thrice daily, live combined Bifidobacterium, Lactobacillus and Streptococcus therophilus tablets 0.5 g thrice daily, and montelukast sodium tablets 1 mg once daily were given orally, and free amino acid-based infant formula was fed. A week later, the infant′s diarrhea and hematocheiza disappeared and fecal occult blood test showed negative.
  • Shi Xiaoping, Lyu Qianzhou, Wang Ting, Xu Qing
    Abstract ( ) PDF ( )
    Two male patients (patient 1, 46 years old; patient 2, 41 years old), who had underwent liver transplantation, received polymyxin B 75 mg (patient 1 175 mg and patient 2 150 mg at the first dose) by IV infusion twice daily because of postoperative infection by Klebsiella pneumoniae. They developed hyperpigmentation on the skin of the head and neck without any change on the rest of the body respectively on day 13 and 15 of the medication. Patient 1 continued to use the drug due to uncontrolled infection. The skin color of the head and neck continued to deepen and then appeared to be dark brown when the patient died of multiple organ failure on day 29 of the medication. Patient 2 stopped using polymyxin B because of the improvement of the condition on day 31 of the medication when the skin color of the head and neck was dark brown. At 4 months of follow-up, his skin color of the head and neck was significantly lighter, but not returned to its original appearance.
  • Wang Daimei, Zhao Eryi, Zhong Jingbo, Han Fangxuan, Lyu Xiuping
    Abstract ( ) PDF ( )
    A 58-year-old male patient received aspirin enteric-coated tablets 200 mg and rosuvastatin calcium 10 mg once daily by mouth, IV infusions of butylphthalide and sodium chloride injection 100 ml (containing butylphthalide 25 mg and sodium chloride 0.9 g) twice daily and troxorutin brain protein hydrolysate 10 ml once daily for acute ischemic stroke. Seven days later, laboratory tests showed blood urea 6.9 mmol/L, serum creatinine (Scr) 131 μmol/L, and blood cystatin C 1.54 mg/L. Kidney injury induced by butylphthalide and sodium chloride injection was considered. Butylphthalide and sodium chloride injection was stopped but the other drugs as well as Xueshuantong for injection (注射用血栓通) and Corbrin capsule (百令胶囊) were given. Laboratory tests showed blood urea 6.2 mmol/L, Scr 104 μmol/L, and blood cystatin C 1.05 mg/L 6 days later and then blood urea 5.9 mmol/L, Scr 101 μmol/L, and blood cystatin C 1.00 mg 2 months later.
  • Zhu Minghui, Gao Yiling, Chen Jun, Yao Feifei
    Abstract ( ) PDF ( )
    A 71-year-old male patient with acute brain stem infarction received an IV infusion of ceftriaxone sodium for injection 3 g, dissolved in 0.9% sodium chloride injection 100 ml, for later pulmonary infection. About 3 hours after completing the infusion, the patient developed red swelling on the hands and feet, and skin redness and rash on multiple parts of the body. About 6 hours after completing the infusion, he developed multiple vesiculobullous on the hands, thighs root and perineum. Bullous epidermal necrolysis drug eruption induced by ceftriaxone sodium for injection was considered. The anti-infective drug was changed to be moxifloxacin and drugs for brain infarction were continued. At the meantime, the patient was given symptomatic supportive treatments such as anti-allergy, topical medication in skin lesions, and visible light treatment at skin ulceration. Five days later, the whole rash subsided.
  • Yuan Fengbo, Kang Man
    Abstract ( ) PDF ( )
    A 70-year-old male patient received pantoprazole because of stomachache with bloody stools for 1 day and positive fecal occult blood test. The laboratory tests before medication showed total bilirubin(TBil) 11.3 μmol/L, direct bilirubin(DBil) 4.0 μmol/L, alkaline phosphatase(ALP) 72 U/L, alanine aminotransferase(ALT) 59 U/L, aspartate aminotransferase(AST) 55 U/L, and glutamyltransferase(γ-GT ) 65 U/L. On day 4 after medication, the patient was diagnosed as ulcerative colitis. Pantoprazole was stopped and cimetidine, mesalazin enteric-coated tablets, compound glutamine entersoluble capsules, and live combined bifidobacterium and lactobacillus tablets were given. After 3 days of treatments, formed stools appeared and abdominal pain and bloody stools disappeared. On day 6, cimetidine was stopped. On day 11, the laboratory tests showed TBil 37.8 μmol/L, DBil 20.8 μmol/L, ALT 660 U/L, AST 236 U/L, γ-GT 424 U/L, and ALP 217 U/L. Drug-induced liver injury was diagnosed. Then mesalazin was withdrawn, other drugs continued, and liver protection treatment was given at the same time. After 10 days of treatment, the laboratory tests showed TBil 21.3 μmol/L, DBil 9.4 μmol/L, ALT 97 U/L, AST 27 U/L, γ-GT 247 U/L, and ALP 122 U/L. At one and a half months of follow-up, no abnormality occurred.
  • Yang Jing, Dai Yang, Fan Hua, Wang Huaguang, Liu Lihong
    2018, 20(6): 468-470.
    Abstract ( ) PDF ( )
    A 50-year-old female patient received  mechanical ventilation via tracheal cannula and continuous venous pump of propofol 1.2 mg/(kg·h) for sedation in surgical intensive care unit (SICU) after liver transplantation. On day 4 after the operation, the ventilator and propofol were discontinued and laboratory test showed myoglobin (Mb) 1 345 μg/L. On day 6 after the operation, the Mb level decreased to 803 μg/L. And on the same day, the mechanical ventilation via tracheal cannula and continuous venous pump of propofol 1.538 mg/(kg·h) for sedation was given again because of pleural effusion and atelectasis. After that, the patient′s Mb level keep increasing and, on day 10 after the operation, it increased to 1 465 μg/L. Propofol was stopped and the Mb level decreased to 638 μg/L 4 days later and then 320 μg/L 11 days later.
  • Huang Wei, Long Peipei
    Abstract ( ) PDF ( )
    A 62-year-old female patient received hemocoagulase for injection 1 KU, added into 10 ml of 0.9% sodium chloride injection in advance, by intravenous injection thrice daily after cholecystectomy. No abnormalities of preoperative blood coagulation test were found. On day 3 after the medication, the patient had extensive capillary hemorrhage from her surgical incision. The blood coagulation test showed prothrombin time (PT) 18 s, international normalized ratio (INR) 1.5, activated partial thromboplastin time (APTT) 36 s, thrombin time (TT) 88 s, fibrinogen (FIB) 0.09 g/L, and D-dimer 3.6 mg/L. Considering that the blood coagulation disorders might be caused by hemocoagulase, it was stopped and aminomethylbenzoic acid injection 0.3 g, added into 100 ml of 0.9% sodium chloride injection in advance, was given by intravenous infusion once daily. In the meantime, vitamin K1 10 mg it was given by intramuscular injection twice daily. The next day, no significant capillary hemorrhage was found in the surgical incision. Five days later, the blood coagulation test showed PT 14 s, INR 1.0, APTT 29 s, TT 20 s, FIB 2.25 g/L, and D-dimer 0.5 mg/L.
  • Wei Lina, Li Ping, Yang Xue, Fu Lei, Cheng Cheng, Sun Wei
    Abstract ( ) PDF ( )
    A 60-year-old male patient with chronic renal failure accompanied by renal hypertension received long-term treatment with amlodipine 10 mg (orally, once daily), captopril 37.5 mg ( orally, thrice daily), and regular hemodialysis (thrice weekly), and his blood pressure was maintained in the range of 150-160/60-70 mmHg. The patient went to the drugstore to buy medicine and the pharmacy clerk sold carbamazepine to him in mistaken for captopril. The patient had taken carbamazepine for 3 days when he found the medication error. Carbamazepine was discontinued by the patient and only amlodipine was taken regularly. Twelve days after captopril withdrawal, the patient developed dizziness, headache, nausea, and vomiting, and his blood pressure was 200/70 mmHg. Three days later, the patient was diagnosed as malignant hypertension and admitted to hospital because his blood pressure increased to 250/100 mmHg. After admission, the patient was given an infusion pump of sodium nitroprusside (1 mg/ml, pump rate 6-8 ml/h) and oral medicines of valsartan and amlodipine tablets (1 tablet, twice daily), terazosin hydrochloride tablets (4 mg, twice daily), and metoprolol succinate sustained-release tablets  (47.5 mg, once daily), and hemodialysis was continued (thrice weekly). On the Sixth day of admission, the infusion pump of sodium nitroprusside was changed to nicardipine (0.6 mg/ml, pump rate 6-11 ml/h). On day 10, the patient′s blood pressure dropped to 150/82 mmHg and oral spironolactone 20 mg thrice daily was added. On day 20, his blood pressure dropped to 124/83 mmHg and then the patient was discharged. At 2 months of follow-up, the patient did not have hypertension again.
  • Ke Wei, Liu Min, Li Yueyang, Wang Xiangfeng
    Abstract ( ) PDF ( )
    An 82-year-old female patient received oral isosorbide mononitrate sustaind-release capsules 50 mg once daily, an IV infusion of Danshen Duofensuan Yan (丹参多酚酸盐) 200 mg dissolved in 5% glucose injection 250 ml once daily, oral itopride 50 mg thrice daily, and oral compound digestive enzyme capsules (Ⅱ) 1 pill thrice daily for unstable angina, coronary atherosclerotic heart disease, and gastroesophageal reflux (GER). On day 3 of treatments, the patient suddenly presented with sweating, fever (39 ℃), accompanied by coarse tremor in limbs and intention tremor in both upper limbs. Blood routine test showed no obvious abnormality. It was considered that itopride induced the extrapyramidal symptoms. Itopril was withdrawn and an IV injection of diazepam 10 mg, physical cooling, and mental comfort were given. About 2 hours later, the patient′s temperature returned to normal and about 8 hours later, the tremor disappeared. Other drugs were continued to use and no similar symptoms recurred.
  • Liu Yang, Chen Jing, Chen Shicai
    Abstract ( ) PDF ( )
    A 64-year-old female patient was suspected of psoriasis due to generalized rash and received oral Xiaoyin granules (3.5 g, thrice daily) and compound amino-polypeptide tablets (5 tablets, thrice daily) following the doctor′s advice of other hospital. After 15 days of medication, the patient developed symptoms such as fatigue, nausea, and anorexia. After 17 days, dark brown urine appeared. After 24 days, the laboratory tests showed ALT 1 500 U/L and TBil 98.5 μmol/L. The Xiaoyin granules and compound amino-polypeptide tablets were immediately discontinued following the doctor′s advice, and 1 day later, the patient was admitted to our hospital. The laboratory tests showed the following results: ALT 1 156 U/L, AST 410 U/L, ALP 259 U/L, γ-GT 198 U/L, TBil 112.8 μmol/L, and DBil 92.5 μmol/L. Ruling out the liver injury caused by viral hepatitis and other factors, drug-induced liver injury was considered. Drugs such as compound glycyrrhizin injection, the reduced glutathione for injection, the methionine vitamin B1 for injection, Chidan Tuihuang granules (赤丹退黄颗粒), ursodeoxycholic acid capsules, and potassium aspartate and magnesium aspartate tablets were given. The rash disappeared and jaundice subsided respectively after 12 and 31 days of the above treatments. Liver function tests after 34 days of the medication showed ALT 19 U/L, AST 17 U/L, TBil 32.9 μmol/L, and DBil 26.0 μmol/L. Through searching the relevant literature reported before, Xiaoyin Granules was very likely related to the liver injury. Cortex Dictamni  contained in the drug is toxic to liver.
  • He Li′en, Bai Wanjun, Dong Zhanjun
    Abstract ( ) PDF ( )
    A 51-year-old female patient underwent resection of lymphatic cyst because of the infection of her pelvic lymphatic cyst after the cervical cancer operation. After the operation, the patient was given sequentially IV infusions of haemocoagulase agkistrodon for injection 2 units (dissolved in 0.9% sodium chloride injection), 10% potassium chloride injection 15 ml (added to 10% glucose injection 500 ml), and polygeline injection 500 ml. When about 100 ml of polygeline injection was infused, the patient suddenly lost consciousness, and her breath rate was 10 times/min, heart rate was 120 beats/min, blood pressure was 70/50 mmHg, and oxygen saturation was 0.70. Pulmonary embolism was considered and respiratory stimulants, hypertensors, and heparin were given, but the patient′s symptoms continued to worsen and her blood pressure dropped to 0. After 28 minutes of the rescue, allergic shock caused by polygelatin peptide injection was considered because of the flushing of the patient′s skin. The polygeline injection was stopped immediately, and then antianaphylaxis and antishock treatments were given. The patient′sblood pressure began to recover but remained unstable. Echocardiography showed more pericardial effusion than before the operation. Pericardiocentesis was urgently implemented, draining about 80 ml of effusion, and the drainage tube was indwelled. Antianaphylaxis and antishock treatments were continued. About 50 minutes later, the patient regained consciousness. And about 11 hours later, her blood pressure was 135/85 mmHg, breath rate was 18/min, heart rate was 100 beats/min, and oxygen saturation was 1.00.